News German pricing rules hit Eisai's Halaven Drug has "no additional benefit" in metastatic liposarcoma, says IQWiG.
Views & Analysis Novartis committed to CAR-Ts - but doubts about commercial v... Novartis may have concerns about commercial prospects, says expert.
News NICE in drive to increase paediatric vaccinations Draft quality standard is response to low uptake.
News Novartis move damages CAR-T confidence Swiss pharma axes gene therapy unit, causing investor angst.
Views & Analysis Digital Health Round-up – DeepMind & UCLH; Google Glass A round-up of this week’s top digital healthcare news. Marco Ricci reports.
Views & Analysis England’s ‘world-first’ cancer database – can it deliver on ... The world's first national database of cancer treatment outcomes has been launched in England.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
